Effective compounds group of Mongolian prescriptions BAIMAI-SAN protect against peripheral neuropathy in lower limbs of rats through neuro protective effect

被引:23
作者
Liu, Qing-Shan [2 ]
Pang, Zong-Ran [2 ]
Liu, Rui [3 ]
He, Guo-Rong [3 ]
Cui, Jian [2 ]
Yin, Xiao-ying [1 ]
机构
[1] Jiangxi Univ Tradit Chinese Med, Coll Pharm, Nanchang 330004, Peoples R China
[2] Minzu Univ China, Natl Res Ctr Minor Med, Beijing 100081, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Pharmaceut Screening, Inst Mat Med, Peking Union Med Coll, Beijing 100050, Peoples R China
关键词
Diabetic neuropathy; Effective compounds group; Motor nerve conduction velocity; Sensory nerve conduction velocity; Neurite length; CILIARY NEUROTROPHIC FACTOR; NERVE;
D O I
10.1016/j.jep.2011.04.026
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: BAIMAI-SAN prescription is a famous Chinese minority complex prescription used for curing neuropathy. Materials and methods: The Effective Compounds Groups of BAIMAI-SAN (ECGBM) is determined by high through-put screening, and it includes picroside II, verbascose, taurine and ellagic acid and borneol. To research the potential protective effect of ECGBM on the function of peripheral neuropathy, diabetic rats with peripheral neuropathy were induced by streptozotocin and treated with ECGBM (0.1, 0.3, 0.9 mg/kg/day i.g.) for 75 days. Primary cortical neuronal cultures were subjected to high d-glucitol, and treated with ECGBM prophylactically. Results: The administration resulted in reductions in speed of sciatic motor nerve conduction velocity (MNCV), sensory nerve conduction velocity (SNCV) and response speed to pain in the sciatic nerve fiber. Data from primary cortical neuronal cultures experiments indicated that neuronal survival rates were increased, and LDH release was decreased and the loss of neurite length was alleviated in ECGBM group. Conclusions: It is first report that ECGBM could protect the peripheral neuron in diabetic rat in vivo and in vitro. This activity may be associated with the neuron protective effect. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:786 / 791
页数:6
相关论文
共 18 条
[1]  
Du GH, 2002, CHIN TRADIT PAT MED, V24, P878
[2]   Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats [J].
Inkster, Melanie E. ;
Cotter, Mary A. ;
Cameron, Norman E. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 561 (1-3) :63-71
[3]   The use of ciliary neurotrophic factor to promote recovery after peripheral nerve injury by delivering it at the site of the cell body [J].
Kelleher M.O. ;
Myles L.M. ;
Al-Abri R.K. ;
Glasby M.A. .
Acta Neurochirurgica, 2006, 148 (1) :55-60
[4]   The novel mechanism of recombinant human ciliary neurotrophic factor on the anti-diabetes activity [J].
Liu, Qing-Shan ;
Gao, Mei ;
Zhu, Shen-Yin ;
Lie, Shao-Jing ;
Zhang, Li ;
Wang, Qiu-Juan ;
Du, Guan-Hua .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (02) :78-84
[5]  
LIU QS, 2010, ENDOCRINOL METAB, V37, P310
[6]   Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro [J].
Liu, Rui ;
Gao, Mei ;
Yang, Zhi-Hong ;
Du, Guan-Hua .
BRAIN RESEARCH, 2008, 1216 :104-115
[7]  
LUCCHETTA M, 2011, NEUROLOGICAL SCI
[8]  
MA HP, 2005, CHINESE J CLIN REHAB, V9, P87
[9]   Complications of Type 1 Diabetes [J].
Melendez-Ramirez, L. Yvonne ;
Richards, Robert J. ;
Cefalu, William T. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (03) :625-+
[10]  
Nicholls Kathy, 2005, Aust Fam Physician, V34, P933